Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Myeloproliferative neoplasms with a low (<5%) CALR mutation allele burden.

Blood cells, molecules & diseases - 1 Sept 2021

Lee Tokar Lisa, Crotty Gerard, O'Keeffe Denis, Langabeer Stephen E

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Calreticulin
Share to Aged
Share to Alleles
Share to Hematologic Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Myeloproliferative Disorders

Share to Neoplasm Proteins

Source

Identifiers

PMID: 34217938
DOI: 10.1016/j.bcmd.2021.102593

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Myeloproliferative neoplasms with a low (<5%) CALR mutation allele burden.PMID 34217938Read ↗

Clinicopathological differences exist between CALR- and JAK2-mutated myeloproliferative neoplasms despite a similar molecular landscape: data from targeted next-generation sequencing in the diagnostic laboratory.Semantic proximity Read ↗

Looking for CALR mutations in familial myeloproliferative neoplasmsSemantic proximity Read ↗

CALR mutation profile in Irish patients with myeloproliferative neoplasms.Semantic proximity Read ↗

Sequential mutational evaluation of CALR -mutated myeloproliferative neoplasms with thrombocytosis reveals an association between CALR allele burden evolution and disease progression.Semantic proximity Read ↗

The characteristics of CALR mutations in myeloproliferative neoplasms: a clinical experience from a tertiary care center in Qatar and a literature review.Semantic proximity Read ↗

A report on the co-occurrence of JAK2V617F and CALR mutations in myeloproliferative neoplasm patients.Semantic proximity Read ↗

Mutation Profile in BCR-ABL1-Negative Myeloproliferative Neoplasms: A Single-Center Experience From India.Semantic proximity Read ↗

The different variant allele frequencies of type I/type II mutations and the distinct molecular landscapes in CALR-mutant essential thrombocythaemia and primary myelofibrosis.Semantic proximity Read ↗

Droplet digital PCR assay for quantifying of CALR mutant allelic burden in myeloproliferative neoplasmsSemantic proximity Read ↗

Detection and characterization of homozygosity of mutated CALR by copy neutral loss of heterozygosity in myeloproliferative neoplasms among cases with high CALR mutation loads or with progressive diseaseSemantic proximity Read ↗

The CALR exon 9 mutations are shared neoantigens in patients with CALR mutant chronic myeloproliferative neoplasmsSemantic proximity Read ↗

JAK2V617F and CALR double mutations are more frequently encountered in patients with low JAK2V617F allelic burdens.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.